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Purpose: Severe circumferential calcification of the outflow artery during lower-extremity distal revascularization is
considered a poor prognostic factor for bypass graft patency. The aim of this study was to assess the influence of
circumferential infrapopliteal arterial calcification on bypass graft patency and limb salvage rates, comparing patency and
limb salvage rates in unclampable calcified distal outflow arteries with those observed in uncalcified distal outflow arteries.
Methods: From July 1990 to July 1997, of 441 distal bypass graft procedures performed by the same surgeon, 69 (16%,
group I) involved unclampable calcified outflow vessels, whereas 83 (19%, group II) outflow vessels were uncalcified; the
other 289 (65%) had varying intermediate degrees of calcification and were not included in this analysis. All procedures
were performed for limb-threatening ischemia and involved standard vein patch angioplasty of the distal anastomotic site,
irrespective of the conduit used. Primary and secondary patency, limb salvage, and survival rates were assessed by using
Kaplan-Meier analysis.
Results: Groups were similar with regard to age, sex, and atherosclerotic risk factors except for a higher incidence of
diabetes mellitus (88% vs 65%, P .001) and renal failure (17% vs 5%, P .01), including dialysis dependency (P .01)
in group I. Gangrene as an indication for surgery was statistically more frequent in group I (49% vs 29%, P  .01). The
distal anastomotic locations and types of conduit involved were similar in the two groups. The femoral inflow level was
used more often in group II (63% vs 38%, P  .003), the popliteal in group I (32% vs 17%, P  .03). Follow-up ranged
from 30 days to 144 months, with a mean of 69 months. None of the patients were lost during the follow-up period.
None of the patients died during the perioperative (30-day) period. Primary patency rates at 1, 3, and 5 years were 84%,
65%, and 52% for group I and 89%, 76%, and 69% for group II (P  .07.). Secondary patency rates at 1, 3, and 5 years
were 96%, 82%, and 78% for group I and 96%, 85%, and 82% for group II (P .58). Limb salvage rates at 1, 3, and 5 years
were 93%, 83%, and 81% for group I and 97%, 90%, and 86% for group II (P  .39).
Conclusions: Distal revascularization to unclampable, severely calcified outflow arteries can achieve much the same results
to those obtained in uncalcified outflow arteries. A circumferentially calcified distal recipient artery should not be
considered a major obstacle to an attempt at limb salvage bypass graft surgery. (J Vasc Surg 2004;39:539-46.)
Many studies have emphasized the excellent long-term
graft patency and limb salvage rates of autogenous venous
reconstructions to tibial outflow vessels in lower-extremity
arterial revascularizations.1-4 When no autogenous saphe-
nous veins (SVs) were available, poor long-term outcomes
were anticipated for prosthetic bypass grafting to distal
arteries,1,5 so some investigators suggested that major am-
putation was a better option than an attempt at revascular-
ization.6 To improve the less-than-optimal patency results
achieved with prosthetic bypass grafts, a variety of adjunc-
tive techniques to use at the distal anastomotic site were
devised,7-15 leading to more than acceptable patency and
limb salvage rates, and prompting an aggressive approach
to limbs that would otherwise have undergone major am-
putation.
The performance of a vascular anastomosis with no
technical errors in small-caliber, often poor-quality vessels
appears to be crucial to the success of such distal revascu-
larizations. Severe circumferential calcification of the target
outflow arteries has generally been regarded as a poor
prognostic factor for graft patency and limb salvage,16,17
either because of the technical difficulties anticipated in the
vascular dissection, proximal and distal control, longitudi-
nal incision and anastomosis, or for hemodynamic reasons,
because the peripheral blood flow diminishes in the pres-
ence of a stiffened vascular bed, presumably because of the
inability to effect vasodilation.18
In the medical literature, many reports have focused
mainly on describing the technical feasibility of revascular-
ization to such “porcelainized” vessels.19-22 Only a few
studies have reported, however, on the effects of circumfer-
ential infrageniculate arterial calcification on distal bypass
graft patency and limb salvage rates.23-25
The aim of this study was to determine the patency and
limb salvage rates of distal arterial revascularizations to
unclampable calcified vessels.
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PATIENTS AND METHODS
In October 2002, a retrospective review was conducted
on all the bypass graft procedures involving distal outflow
vessels performed by the same surgeon at our institution
from July 1990 to July 1997. The following data were
collected and analyzed: patient demographics, preoperative
risk factors, operative indications, inflow and outflow sites,
postoperative management, and perioperative and postop-
erative complications.
The site of the potential outflow artery chosen for the
distal anastomosis was classified during surgery as normal or
as having mild-to-moderate uncalcified plaque, mild-to-
moderate calcification, or severe calcification.
Overall, 441 distal bypass graft procedures were per-
formed; 69 (16%, group I) of them involved vessels with
severe circumferential calcification, demanding the use of
intraluminal vascular occluders to ensure arterial flow con-
trol, which proved impossible with standard vessel loops or
atraumatic vascular clamps. No calcification was found at
the distal anastomotic site in 83 of 441 distal procedures
(19%, group II). Thus, 152 distal vascular reconstructions
fitted into the extreme categories for distal arterial calcifi-
cation, whereas the other 289 (65%) had varying interme-
diate degrees of calcification and were not included in this
analysis. All bypass graft procedures considered in this series
were primary procedures; in addition, none of the proce-
dures were aborted or incomplete, and none of the patients
were refused arterial revascularization for technical reasons
emerging at the distal anastomotic site.
All patients underwent contrast arteriography preoper-
atively to plan the appropriate revascularization. Runoff
scores were assessed as recommended by the Ad Hoc
Committee on Reporting Standards.26 The preferred con-
duit was the reversed autogenous SV, which was harvested
whenever possible on the strength of venous mapping by
duplex scan and always after a direct evaluation at surgery.
Alternatively, composite (prosthetic/autogenous SV) or
prosthetic grafts (8 mm, polytetrafluoroethylene [PTFE];
thin-walled expanded PTFE [Gore-tex; W.L. Gore, Flag-
staff, Ariz]) were used when the ipsilateral or contralateral
SV was unavailable because it had been used for previous
procedures or was unsuitable, ie too short, poor quality, or
not compliant (less than 2 mm in size). All composite grafts
were straight and the prosthetic component was PTFE.
The prosthetic/reversed SV anastomosis was performed in
an end-to-end fashion by means of a beveled “hand-clasp”
technique using either 5/0 or 6/0 Prolene (Ethicon, Inc,
Somerville, NJ) suture. The autogenous SV was always
implanted distally, and no attempt was made to prevent
crossing the knee with the prosthetic portion of the com-
posite graft.
All revascularizations were performed by using regional
anesthesia (epidural or spinal) and administering intrave-
nous heparin (5000 IU) before clamping: the heparin was
not reversed with protamine. The artery chosen as the
inflow site was exposed in standard fashion. Distal exposure
methods varied according to the vessel chosen for the
bypass graft procedure. The peroneal artery was always
exposed by using a lateral approach that required segmental
fibulectomy. After proximal and distal arterial exposure, the
distal anastomosis was performed first. If there was no
calcification, proximal and distal backflow was controlled
with vessel loops. If severe circumferential calcification was
found, hemostasis with multiple serial vessel loops or atrau-
matic clamps was impossible, so the arterial backflow was
controlled by using graduated olive-type metal intraluminal
vessel occluders (caliber 2-5 mm, intermediate sizes). All
distal anastomotic sites, with or without calcification, un-
derwent standard vein patch angioplasty no longer than 3
cm, as described elsewhere.27 The vein for the patch was
harvested from any available location, including saphenous
remnants, arm veins harvested under local anesthesia, and,
occasionally, collaterals of the SV. The venous segment was
cut to the appropriate length and width in preparation for
the patch. In most cases, the width was left unaltered to
create a generous patch to allow for it to bulge under
arterial flow, rather like a cuff. The vein width was some-
times trimmed to ensure a better size match with a small
tibial artery.
Unclampable distal outflow anastomotic techni-
que. The calcified anastomotic site was chosen after prox-
imal/distal dissection extended 5 to 6 cm at most and
palpation of the vessel had failed, in an attempt to identify
soft segments that could be used for proximal and distal
clamping. The chosen site was exposed on its external
surface, removing the perivascular tissue only in the specific
area. An arteriotomy was performed by scoring the artery
with a number 11 or 15 blade to reach the lumen, taking
care to avoid any transversal fragmentation of the calcified
plaque and extending the incision a further 2.5 to 3 cm.
with fine Potts scissors. The arteriotomy is then gently
widened by means of a right-angled instrument. The lim-
ited blood flow encountered was removed by suction to
ensure the accurate proximal and distal placement of an
appropriately sized internal occluder with a flexible shaft
attached to the metal head, exerting no force and under
direct vision (Fig 1, A). A vein patch was routinely sutured
to the calcified vessel with simple running 6/0 Prolene
stitches on cardiovascular cutting needles, passing the su-
ture from the vein to the artery (Fig 1, B). Before the patch
anastomosis was completed, a longitudinal venotomy was
performed to enable the subsequent implantation of the
chosen conduit in the vein patch. The conduit (SV, com-
posite, or prosthetic material) was then anastomosed to the
vein patch with a continuous 5/0 Prolene suture, leaving a
rim of venous tissue between the conduit and the calcified
arterial wall (Fig 1, C). After terminating this secondary
anastomosis, intraluminal occluders were removed from
the primitive arteriotomy by gentle traction, ensuring pa-
tency of the anastomosis. The suture was then tied with an
appropriate tension, eliminating anastomotic bleeding (Fig
1, D). If suture-hole bleeding persisted on the calcified
artery, it was easily controlled with thrombin-soaked oxi-
dized cellulose and digital pressure.
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The conduit was always routed through the interosse-
ous membrane when the anterior tibial artery was used as
the outflow vessel, whereas it was routed in the standard
fashion when the peroneal artery or posterior tibial artery
was used. A heparin infusion was started 6 to 10 hours
postoperatively with oral warfarin (Coumadin; Du Pont De
Nemours, Wilmington, Del) administered on the first post-
operative day. Long-term anticoagulation treatment with
Coumadin was continued for 6 months, aiming for a nor-
malized ratio between 2 and 4. After 6 months, 325 mg
aspirin was taken daily.
Graft surveillance. End points of the study were pri-
mary and secondary patency and limb salvage rates, and
death. Postoperative evaluations included a physical exam-
ination, pulse volume recordings, and duplex scans in all
patients at discharge, at 4 weeks, then at 3, 6, and 12
months, and every 6 months thereafter. Graft patency was
assessed on the strength of the presence of a palpable distal
pulse, or the ankle/brachial pressure index, or a patent graft
on duplex scan. The graft was considered as failing if
ischemic symptoms returned despite a palpable pulse, or if
a discrete change in Doppler signal suggested stenosis
along the conduit. Patients with failing grafts underwent
repeat arteriography and revision or replacement of their
bypass graft whenever possible. As for graft patency, the
data on patients who died stopped at the last time their graft
had been found patent. Each end point was taken as the
middle of the interval between when the graft had last been
documented as being patent and when it was revised or
clearly shown to be occluded. Limb salvage was defined as
preservation of the affected limb with no need for amputa-
tion above the metatarsal level. All the criteria used for this
analysis attempted to conform to the standards suggested
by the Ad Hoc Committee of the Joint Council of the
Vascular Societies for Reports Dealing with Lower Extrem-
ity Ischemia.26
Statistical analysis. Continuous data were compared
with Student t test. Frequencies and categorical data were
compared with a 2 or Fisher exact test, as appropriate. A
Cox proportional hazard multivariate analysis was used to
Fig 1. A, After performing a longitudinal arteriotomy in the unclampable calcified vessel, olive-type metal intraluminal
occluders are placed to control proximal and distal backflow. B, A vein patch is routinely sutured to the calcified artery
with simple running stitches on cardiovascular needles. C, Before the patch anastomosis is completed, the chosen
conduit is implanted in the vein patch. D, Intraluminal occluders are removed from the primitive anastomosis and then
the suture is tied.
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determine which factors could influence bypass graft pa-
tency and limb salvage. All tests were two-tailed, and sta-
tistical significance was inferred at P  .05. Primary and
secondary patency, limb salvage, and survival rates were
assessed by using Kaplan-Meier analysis, and data were
compared with the log-rank test.
RESULTS
Sixty-five patients in group I underwent 69 bypass
grafts (4 were bilateral), whereas 78 patients in group II
had 83 bypass grafts (5 bilateral). Follow-up ranged from
30 days to 144 months, with a mean of 69 months. None of
the patients were lost during the follow-up period. None of
the patients had a concurrent inflow procedure along with
the distal revascularization. The baseline characteristics of
the 143 patients are given in Table I. Groups were similar in
terms of age, sex, and most atherosclerotic vascular risk
factors. The incidence of diabetes mellitus and renal failure
(defined as a serum creatinine level higher than 2.0 mg/
dL) was statistically higher in group I (88% vs 65%, P 
.001, and 17% vs 5%, P .01, respectively). Moreover, of
the 16 patients with renal failure, 5 (all in group I) were on
dialysis (P  .01). All bypass graft procedures were per-
formed for limb-threatening ischemia (Table II). The pres-
ence of gangrene was significantly higher in group I (49% vs
29%, P  .01). The inflow and outflow arteries chosen for
the anastomotic sites and bypass graft conduits are shown
in Table III. The femoral inflow level was used significantly
more in group II (63% vs 38%, P  .003), the popliteal in
group I (32% vs 17%, P  .03). There were no differences
in the level of the distal outflow site. The type of conduit
used was similar in the two groups, the SV being preferred
in 77% and 67% of the group I and II procedures, respec-
tively.
Perioperative mortality and morbidity data. None
of the patients died during the perioperative (30-day) pe-
riod. The perioperative complication rates were compara-
ble in the two groups (Table IV). The 30-day graft patency
rate was 99% for group I, with only one early failure, leading
to an above-knee amputation; in group II, two early graft
failures occurred, meaning a 30-day primary patency rate of
98%.
Long-term results. The primary patency results are
reported in Fig 2. At 1, 3, and 5 years, they were 84%, 65%,
and 52% for group I and 89%, 76%, and 69% for group II
(P  .07). Secondary patency was successfully restored in
14 grafts in group I and in 13 grafts in group II (Fig 3). At
1, 3, and 5 years, the secondary patency rates were 96%,
82%, and 78% for group I and 96%, 85%, and 82% for group
II (P  .58). In group I, 9 failed bypass grafts (4 PTFE, 3
composite, and 2 SV grafts) were thrombectomized
and/or lysed without any underlying anatomical defect
being found as the cause of graft failure. All these grafts
failed within the first 2 years after surgery. Two failed SV
bypass grafts had a revision of the distal anastomosis be-
cause of myointimal proliferation and hyperplasia: the SV
graft was detached close to the vein patch that was re-
moved; the recipient vessel was thrombectomized until a
satisfactory runoff was observed; a new vein patch was
sutured to the calcified artery and the original lysed SV graft
was then reimplanted in the patch, with no need to perform
a more caudal anastomosis. The remaining 3 bypass grafts
(1 SV, 1 composite, and 1 PTFE grafts) failed because of
progression of the inflow disease. The primitive anastomo-
sis had been performed at the level of the distal superficial
femoral artery (n  1), the above-the-knee artery (n  1),
and below-the-knee popliteal artery (n  1), respectively.
Thrombectomy/lysis and revision (proximal graft exten-
sion) were successfully performed in these cases. Seven
below-knee and five above-knee amputations (17%) were
performed in group I, as opposed to eight below-knee and
two above-knee amputations (10%) in group II. At 1, 3,
and 5 years, the resulting limb salvage rates were 93%, 83%,
and 81% for group I and 97%, 90%, and 86% for group II
(P  .39) (Fig 4). The Cox analysis showed no significant
influence of the risk factors considered (diabetes mellitus
and renal failure), inflow and outflow sites, severe arterial
calcification, and the presence of gangrene on bypass graft
patency or limb salvage in the two groups.
Table 1. Demographics and risk factors
Severe
calcification,
n (%)
No
calcification,
n (%) P
No. of patients 65 78
No. of procedures 69 83
Age (y)
Mean 73 75
Range 56–91 58–90
Men 51 (78) 58 (74) .59
Risk factors
Diabetes mellitus 61 (88) 54 (65) .001*
Diet controlled 7 (10) 5 (6) .38
Oral agent 20 (29) 16 (19) .18
Insulin dependent 34 (49) 33 (40) .31
Smoking† 58 (84) 59 (71) .08
CAD 55 (78) 61 (73) .44
Prior CABG 13 (19) 18 (23) .69
Prior stroke 10 (14) 14 (17) .82
Hypertension‡ 42 (61) 52 (63) .86
Creatinine  2.0 mg/dL 12 (17) 4 (5) .01*
Dialysis 5 (7) 0 .01*
Prior inflow procedures 11 (16) 10 (12) .63
CAD, Coronary artery disease; CABG, coronary artery bypass grafting.
*Determined by Fisher test.
†Defined by patient history.
‡Defined as blood pressure treated with medication.
Table II. Indications for surgery
Severe
calcification,
n (%)
No
calcification,
n (%) P
Ulcer 15 (22) 26 (31) .20
Gangrene 34 (49) 24 (29) .01*
Rest pain 20 (29) 33 (40) .17
*Determined by Fisher test.
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Overall, there were 43 late deaths, 19 in group I and 24
in group II. The 5-year patient survival rate was 71% in
group I and 69% in group II.
DISCUSSION
Although distal revascularization to tibial arteries has
proved a durable and effective procedure for limb salvage in
critically ischemic foot, the management of unclampable
calcified but otherwise patent outflow arteries remains a
challenging and often frustrating problem for the vascular
surgeon.16,17,23-25,28-31 This problem is such that patients
with severe circumferential calcification at the distal anas-
tomotic site are sometimes not considered for any attempt
at reconstruction and are treated with primary amputation.
In this study, primary and secondary graft patency and
limb salvage rates of distal revascularizations to unclam-
pable infrageniculate calcified target arteries were compa-
rable with those obtained in uncalcified outflow arteries,
although they were lower for the calcified group in all
analyses, with a slight trend toward significance in the
5-year primary patency rate (P  .07). Our study consid-
ered revascularizations in the extreme categories of distal
arterial calcification, so intermediate degrees of calcification
(which account for more than 60% of procedures) might be
expected to have similarly favorable patency rates. Al-
though, to our knowledge, this is the first series dealing
with revascularization of such severely calcified outflow
arteries to report 5-year graft patency and limb salvage
rates, these findings correlate well with previous reports
restricted to a follow-up no longer than 36 months.23-25 In
a series of 36 distal revascularizations to heavily calcified,
“rock-like” arteries performed by Ascer et al,23 the 3-year
cumulative patency and limb salvage rates were 47% and
75%, respectively, with no statistical difference when this
group was compared with uncalcified and mild-to-moder-
ately calcified groups. Similarly, Rubin et al24 showed that
3-year primary graft patency and limb salvage rates (both
80%) observed in 35 patients who had 38 femorotibial
bypass grafts to calcified arteries did not differ significantly
from rates recorded in bypass grafts to uncalcified vessels.
In the largest series published to date comparing distal
revascularizations involving unclampable calcified outflow
arteries (n  101) with uncalcified outflow arteries (n 
105), Misare et al25 reported 2-year primary and secondary
patency and foot salvage rates of 66%, 69%, and 77% for the
severely-calcified group and 84%, 90%, and 96% for the
uncalcified group. Although patency and limb salvage rates
were consistently lower for the former in all analyses, the
differences were not significant at 2-year follow-up.
Lower-extremity arterial calcification (because of either
calcification of atherosclerotic intimal plaque or medial
calcification) is a common feature among patients with
peripheral atherosclerotic disease, whereas extensive vascu-
lar calcification (mainly confined to the tunica media of the
arterial wall and preferentially involving crural vessels) is
most frequently recognized in patients with chronic renal
failure and diabetes mellitus.25,28-31 Results from this study
confirmed this evidence, showing that there was a higher
incidence of patients with diabetes and patients with high
creatinine levels and dialysis dependency in group I (88% vs
65%, P .001; and 17% vs 5%, P .01). This finding could
explain the more frequent use of a more distal inflow
site—usually the popliteal artery—in group I (32% vs 17%,
P  .03), limiting the length of the conduit required and
also avoiding potentially troublesome groin dissection. It
could likewise explain the more proximal inflow level—into
the common femoral artery—in group II (63% vs 38%, P
.003). Other investigators have described similar patterns,
obtaining inflow from the popliteal artery in more than 50%
of revascularizations of very distal bypass grafts performed
for limb salvage in a patient population that was mainly
diabetic or had chronic renal failure.25,28-31
Table III. Inflow artery, outflow artery, and conduit
used in distal revascularizations
Severe
calcification,
n (%)
No
calcification,
n (%) P
Inflow
Common femoral 26 (38) 52 (63) .003*
Distal SFA/ AK popliteal 21 (30) 17 (20) .18
BK popliteal/TPT 22 (32) 14 (17) .03*
Total 69 (100) 83 (100)
Outflow
TPT 4 (6) 10 (12) .26
Peroneal 16 (23) 15 (18) .54
Anterior tibial 17 (25) 18 (22) .70
Posterior tibial 15 (22) 22 (26) .57
Pedal 16 (23) 18 (22) .84
Tarsal/plantar 1 (1) 0 .45
Total 69 (100) 83 (100)
Conduit
Reversed saphenous vein 53 (77) 56 (67) .21
Composite vein 3 (4) 4 (5) .99
PTFE 13 (19) 23 (28) .25
Total 69 (100) 83 (100)
SFA, Superficial femoral artery; AK, above knee; BK, below-knee; TPT,
tibioperoneal trunk; PTFE, polytetrafluoroethylene.
*Determined by Fisher test.
Table IV. Systemic and local perioperative complications
Severe
calcification,
n (%)
No
calcification,
n (%) P
Systemic complications
Nonfatal myocardial infarction 1 (1) 2 (2) .99
Heart failure 3 (4) 2 (2) .65
Hemorrhage 0 1 (1) .99
Pneumonia 2 (3) 2 (2) 1
Arrhythmia 4 (6) 4 (5) .99
Urinary tract infection 3 (4) 4 (5) .99
Renal failure 1 (1) 0 .45
Local complications
Hematoma 3 (4) 3 (4) .99
Lymphocele 6 (9) 5 (6) .54
Wound dehiscence 2 (3) 0 .20
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Fig 3. Kaplan-Meier life table analysis of secondary patency rates between groups I and II. Number of limbs at risk for
each interval time is shown for each group. Percentages on the right represent the secondary patency rates at 60 months
for the two groups; there was no statistical difference (P  .58).
Fig 4. Kaplan-Meier life table analysis of limb salvage rates between groups I and II. Number of limbs at risk for each
interval time is shown for each group. Percentages on the right represent the limb salvage rates at 60 months for the two
groups; there was no statistical difference (P  .39).
Fig 2. Kaplan-Meier life table analysis of primary patency rates between groups I and II. Number of limbs at risk for
each interval time is shown for each group. Percentages on the right represent the primary patency rates at 60 months
for the two groups; the difference did not reach significance (P  .07).
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Several methods have been described for achieving
hemostasis and constructing the anastomosis in distal un-
clampable arteries.19-25 In our experience, proximal and
distal arterial control with intraluminal occluders has
proved safe and effective. No special techniques, such as
segmental arterial fracturing using hemostats to apply
atraumatic vascular clamps or standard vessel loops, or the
tourniquet technique proposed by several research-
ers,19,23,24 were used to control the calcified target vessel:
care was always taken to preserve intimal integrity, how-
ever. In addition, like Misare et al25 and unlike Ascer et al23
and Rubin et al,24, we found it unnecessary to resort to
other tools (eg, local endarterectomy or partial calcium or
plaque fracturing, Keith needles, or dental drills) to pierce
the calcified wall using the cardiovascular cutting needles.
Interposing venous tissue at the distal anastomotic site
to prevent occlusion by intimal hyperplasia,5,7-11 like the
construction of a remote arteriovenous fistula to increase
graft blood flow in high outflow resistance systems,12-15
have been advocated in an attempt to improve the generally
poor early and late outcome of PTFE bypass grafts with a
direct anastomosis to the infrapopliteal arteries. To our
knowledge, no researchers (apart from Linton and Wilde32
who originally described the use of autogenous vein
patches to overcome technical difficulties encountered in
anastomosing small-caliber, thin-walled vein conduits to
thick-walled diseased arteries) have reported on the use of
venous patch angioplasty at distal anastomotic level when
the conduit was the autologous SV. Since 1986, however,
our technique has involved standard vein patching and
subsequent implantation of the chosen conduit in the patch
in all procedures with distal anastomoses performed below
the knee.27 The end-to-side anastomosis of an 8-mm PTFE
graft or a smaller diameter SV conduit to thick, diseased/
calcified infrageniculate artery, a situation in which even a
minor error can lead to graft failure, is extremely simplified
by interposing the vein patch. The patch is technically easier
to suture, and the secondary suture line between the con-
duit and the vein becomes more technically appealing, even
in the case of the SV.
A further feature of this study is that all patients had
adequate anticoagulation therapy. Complementary therapy
with Coumadin in patients needing arterial reconstruction
to infrapopliteal vessels is often described as an important
factor in improving the patency rates of bypass prosthetic
grafts.7,8,14 Ascer et al14 obtained a 3-year patency rate of
62% by using a remote distal arteriovenous fistula, with
limb salvage in 78% of cases receiving anticoagulation treat-
ment with heparin and warfarin. These results were com-
parable with series using arm veins and with cases in which
anticoagulation was used alone.7,8,14,33 However, the ben-
efit of anticoagulation in patients who have undergone
venous distal revascularization remains to be clearly dem-
onstrated.
Because we used either vein patch angioplasty or anti-
coagulation therapy in all our distal revascularizations, we
are unable to establish the influence of each of these factors
in improving patency rates. However, we obtained more
than acceptable long-term patency and limb salvage rates
by using these techniques in arterial revascularizations to
infrageniculate arteries, demonstrating that unclampable
calcified outflow arteries are not a major obstacle to suc-
cessful lower-extremity arterial revascularization in patients
with limb-threatening ischemia.
In conclusion, the results emerging from this series
support the short-term findings of previous studies and
show that patients who need distal revascularization to
unclampable calcified arteries have acceptable long-term
patency and limb salvage rates that are comparable with
those observed in uncalcified target arteries.
REFERENCES
1. Veith FJ, Gupta SK, Ascer E, White Flores SA, Samson RH, Scher LA,
et al. Six-year prospective multicenter randomized comparison of autol-
ogous saphenous vein and expanded polytetrafluoroethylene grafts in
infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-14.
2. Londrey GL, Ramsey DE, Hodgson KJ, Barkmeier LD, Sumner DS.
Infrapopliteal bypass for severe ischemia: Comparison of autogenous
vein, composite and prosthetic grafts. J Vasc Surg 1991;13:631-6.
3. Neale ML, Graham JC, Lane RJ, Cheung DS, Appleberg M. The
influence of graft type on patency of infrainguinal arterial bypass grafts.
J Am Coll Surg 1994;178:155-63.
4. Sayers RD, Raptis S, Berce M, Miller JH. Long-term results of femoro-
tibial bypass with vein or polytetrafluoroethylene. Br J Surg 1998;85:
934-8.
5. Stonebridge PA, Prescott RJ, Ruckley CV, for the Joint Vascular
Research Group. Randomized trial comparing infrainguinal polytetra-
fluoroethylene bypass grafting with and without vein interposition cuff
at the distal anastomosis. J Vasc Surg 1997;26:543-50.
6. Yeager RA, Hobson RW II, Jamil Z, Lynch TG, Lee BC, Jain K.
Differential patency and limb salvage for polytetrafluoroethylene and
autogenous saphenous vein in severe lower extremity ischemia. Surgery
1982;91:99-103.
7. Flinn WR, Rohrer MJ, Yao JS, McCarthy WJ III, Fahey VA, Bergan JJ.
Improved long-term patency of infragenicular polytetrafluoroethylene
grafts. J Vasc Surg 1988;7:685-90.
8. Parsons RE, Suggs WD, Veith FJ, Sanchez LA, Lyon RT, Marin ML, et
al. Polytetrafluoroethylene bypasses to infrapopliteal arteries without
cuffs or patches: A better option than amputation in patients without
autologous vein. J Vasc Surg 1996;23:347-56.
9. Taylor RS, Loh A, McFarland RJ, Cox M, Chester JF. Improved
technique for polytetrafluoroethylene bypass grafting: Long-term re-
sults using anastomotic vein patches. Br J Surg 1992;79:348-54.
10. Miller JH, Foreman RK, Ferguson L, Faris I. Interposition vein cuff for
anastomosis of prosthesis to small artery. Aust N Z J Surg 1994;54:
283-5.
11. Wolfe JH, Tyrrel MR. Venous patches, collars, and boots improve the
patency rates of polytetrafluoroethylene grafts. Adv Vasc Surg 1995;3:
134-43.
12. Dardik H, Berry SM, Dardik A, Wolodiger F, Pecoraro J, Ibrahim IM,
et al. Infrapopliteal prosthetic graft patency by use of the distal adjunc-
tive arteriovenous fistula. J Vasc Surg 1991;13:685-91.
13. Jacobs MJ, Reul GJ, Gregoric ID, Ubbink DT, Tordoir JH, Kitslaar PJ,
et al. Creation of a distal arteriovenous fistula improves microcirculatory
hemodynamics of prosthetic graft bypass in secondary limb salvage
procedures. J Vasc Surg 1993;18:1-9.
14. Ascer E, Gennaro M, Pollina RM, Ivanov M, Yorkovich WR, Ivanov M,
et al. Complementary distal arteriovenous fistula and deep vein inter-
position: A five-year experience with a new technique to improve
infrapopliteal prosthetic bypass patency. J Vasc Surg 1996;24:134-43.
15. Kreienberg PB, Darling RC III, Chang BB, Paty PSK, Lloyd WE, Shah
DM. Adjunctive techniques to improve patency of distal prosthetic
bypass grafts: Polytetrafluoroethylene with remote arteriovenous fistu-
lae versus vein cuffs. J Vasc Surg 2000;31:696-701.
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 3 Ballotta et al 545
16. Dardik H, Ibrahim IM, Dardik II. The role of the peroneal artery for
limb salvage. Ann Surg 1979;189:189-98.
17. Karmody AM, Leather RP, Shah DM, Corson JD, Naraynsingh V.
Peroneal artery bypass: A reappraisal of its value in limb salvage. J Vasc
Surg 1984;1:809-16.
18. Christensen NJ. Muscle blood flow, measured by and vascular calcifi-
cations in diabetics. Acta Med Scand 1968;183:449-54.
19. Semel L, Schu W, Aust JC, Bredenberg CE. Atraumatic control in
calcified arteries. Ann Vasc Surg 1988;2:73-4.
20. White JV, Gass J. Preparation of the calcified tibial artery for bypass
grafting. Surg Gynecol Obstet 1990;171:165-6.
21. Shindo S, Tada Y, Sato O, Miyata T, Shirakawa M, Egami J, et al.
Esmarch’s bandage technique in distal bypass surgery. J Cardiovasc
Surg 1992;33:609-12.
22. Wagner WH, Treiman RL, Cossman DV, Cohen JL, Foran RF,
Treiman GS, et al. Tourniquet occlusion technique for tibial artery
reconstruction. J Vasc Surg 1993;18:637-47.
23. Ascer E, Veith FJ, White Flores SA. Infrapopliteal bypasses to heavily
calcified rock-like arteries. Management and results. Am J Surg 1986;
152:220-3.
24. Rubin JR, Persky J, Lukens MC, Plecha EJ, Graham LM. Femoral-tibial
bypass for calcific arterial disease. Am J Surg 1989;158:146-50.
25. Misare BD, Pomposelli FB Jr, Gibbons GW, Campbell DR, Freeman
DV, LoGerfo FW. Infrapopliteal bypasses to severely calcified, unclam-
pable outflow arteries: Two-year results. J Vasc Surg 1996;24:6-16.
26. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et
al. Recommended standards for reports dealing with lower extremity
ischemia: Revised version. J Vasc Surg 1997;26:517-38.
27. Ballotta E, Alvino S, Franceschi L, Grego F, Deriu GP. An effective
surgical technique for limb salvage in femorodistal bypass. Vasc Surg
1988;22:154-9.
28. Quinones-Baldrich WJ, Colburn MD, Ahn SS, Gelabert HA, Moore
WS. Very distal bypass for salvage of the severely ischemic extremity.
Am J Surg 1993;166:117-23.
29. Pomposelli FB Jr, Marcaccio EJ, Gibbons GW, Campbell DR, Freeman
DV, Burgess AM, et al. Dorsalis pedis arterial bypass: Durable limb
salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg
1995;21:375-84.
30. Chang BB, Paty PSK, Shah DM, Kaufman JL, Leather RP. Results of
infrainguinal bypass for limb salvage in patient with end-stage renal
disease. Surgery 1990;108:742-7.
31. Whittmore AD, Donaldson MC, Mannick JA. Infrainguinal reconstruc-
tion for patients with chronic renal insufficiency. J Vasc Surg 1993;17:
32-41.
32. Linton RR, Wilde WL. Modifications in the technique for femoropop-
liteal saphenous vein bypass autografts. Surgery 1970;67:234-48.
33. Harward TR, Coe D, Flynn TC, Seeger JM. The use of arm vein
conduits during infrageniculate arterial bypass. J Vasc Surg 1992;16:
420-7.
Submitted Jun 16, 2003; accepted Sep 20, 2003.
CME tests and credits
The Journal of Vascular Surgery is now able to provide CME credits from the online version.
Visitors to the Web site are encouraged to try the tests. Access to the tests is free. If a passing grade is obtained,
CME credits are granted by the American Association for Vascular Surgery and the Society for Vascular Surgery.
JOURNAL OF VASCULAR SURGERY
March 2004546 Ballotta et al
